In summary, this study demonstrates that chronic alcoholic liver disease can be rescued by treatment with PPAR agonists, similar to those used for diabetes mellitus and nonalcoholic steatohepatitis [28–32]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.